PharVision Advisers »

Rxo shares owned by PharVision Advisers

Quarter-by-quarter ownership of Rxo (RXO) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Rxo

Tip: Access up to 7 years of quarterly data

All positions including Rxo held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rxo by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $203k 13k 15.38

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Rxo

Orbis Allan Gray
MFN Partners Management
BlackRock
Vanguard Group
Wellington Management Company
Finepoint Capital
Fil
State Street Corporation
Douglas Lane & Associates
Geode Capital Management
Franklin Resources
Charles Schwab Investment Management
UBS Group
Morgan Stanley
Dimensional Fund Advisors

View all funds holding Rxo